RECON SPINE LLC

RECON SPINE LLC specializes in the design, manufacturing, and supply of advanced surgical implants and electromedical devices tailored for veteran healthcare needs. Their core capabilities center on precision surgical instrumentation, renal intervention systems, and radiation protection equipment for minimally invasive procedures. The company demonstrates deep technical expertise in implantable medical devices, ultrasound-guided renal therapies, and integrated procedural supply chains, with a focus on FDA-regulated Class II and III medical devices. Their specialization in endovascular and interventional platforms—particularly renal denervation systems and radiation-shielded surgical kits—positions them as a niche provider for complex, high-acuity clinical applications within VA facilities. The Department of Veterans Affairs is their exclusive and longstanding partner, with a consistent pattern of awarding contracts for critical implantable devices and procedural supplies used in urological, cardiovascular, and orthopedic interventions. RECON SPINE LLC delivers mission-critical components that support VA’s specialty care pathways, particularly in renal health and surgical reconstruction, indicating a trusted, responsive relationship built on reliability and regulatory compliance. Their industry focus is firmly anchored in surgical and medical instrument manufacturing, with secondary involvement in surgical appliance and electromedical apparatus production. This vertical specialization enables them to serve the interventional radiology and surgical implant markets with clinically validated, single-use and reusable devices that meet stringent FDA and ISO 13485 standards. As a Service-Disabled Veteran-Owned Business headquartered in Saint Charles, Missouri, RECON SPINE LLC operates as a small, agile manufacturer with a mission-driven focus on serving the veteran healthcare ecosystem. Their 2L entity structure reflects a lean, specialized operational model optimized for rapid procurement response and regulatory adherence within federal medical supply chains.